SINGAPORE, April 30 (Bernama-BUSINESS WIRE) -- A.M. Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” of Vietnam National Reinsurance Corporation (VINARE) (Vietnam). The outlook of these Credit Ratings (ratings) is stable.
The ratings reflect VINARE’s balance sheet strength, which A.M. Best categorizes as very strong, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management. VINARE’s risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR), is supported by its low net and gross underwriting leverage. The company’s investment portfolio is conservative, with a majority of its assets invested in cash and deposits. VINARE has maintained good operating performance throughout the past five years, driven by underwriting and investment activities. The company achieved an average combined ratio of approximately 87% from 2013 to 2017, lower than many direct insurers in Vietnam and its peers across the region. In terms of business profile, VINARE continues to receive support from its shareholders, namely the State Capital Investment Corporation, Swiss Reinsurance Company Ltd (Swiss Re) and other direct insurers in Vietnam, which are also its cedants. Swiss Re, VINARE’s second-largest shareholder, provides the company with technical support and modeling capabilities. An offsetting rating factor is the company’s low earnings retention. This could impede capital growth relative to its cedants, which are experiencing capital increases from organic growth and foreign investment. In addition, Vietnam continues to attract international and regional reinsurance capacity. While VINARE is well-positioned at its current rating level, negative rating actions may arise from material deterioration in its operating performance or risk-adjusted capitalization. |
Monday 30 April 2018
A.M. BEST AFFIRMS CREDIT RATINGS OF VIETNAM NATIONAL REINSURANCE CORPORATION
Crownbio launches new target model for immunotherapy
SAN DIEGO, April 27 (Bernama) -- Crown Bioscience, a wholly-owned
subsidiary of Crown Bioscience International has enhance its existing portfolio
of humanised drug target models by launching a new transgenic CD3E model to
advance development of immuno-oncology (I/O) drugs.
CrownBio addresses this need with their new CD3E transgenic model that was validated in collaboration with and developed by NBRI of Nanjing University, a statement said.
NBRI is a leading company in China providing high-quality human disease related animal models for biomedical community as well as pharmaceutical companies.
Novel therapeutic T-cell redirecting antibodies, including bispecific T cell engagers, show great promise in effectively treating cancer. However, development of these drugs is hampered by a lack of in vivo models that can accurately recapitulate human specific responses.
The CD3E model expresses the human form of CD3E and is phenotypically normal with levels of T, B, and NK cells comparable to control. These features make it an ideal model for determining the efficacy of CD3 targeted T cell redirecting therapies through direct assessment of T cell activation, antigen recognition and related intracellular signal transduction pathways.
"Data generated from our new CD3E models demonstrate their unique ability to guide development of bispecific T cell engagers and other T cell redirecting therapies," said Dr Davy Ouyang, Director of Translational Oncology at CrownBio. "We are very excited about the potential these innovative models have to uncover new insights in the discovery and development of cutting-edge I/O agents."
Crown Bioscience is a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research.
Learn more about CrownBio's new CD3E model by visiting https://www.crownbio.com/immuno-oncology/hugemm/cd3e-mouse-model
-- BERNAMA
CrownBio addresses this need with their new CD3E transgenic model that was validated in collaboration with and developed by NBRI of Nanjing University, a statement said.
NBRI is a leading company in China providing high-quality human disease related animal models for biomedical community as well as pharmaceutical companies.
Novel therapeutic T-cell redirecting antibodies, including bispecific T cell engagers, show great promise in effectively treating cancer. However, development of these drugs is hampered by a lack of in vivo models that can accurately recapitulate human specific responses.
The CD3E model expresses the human form of CD3E and is phenotypically normal with levels of T, B, and NK cells comparable to control. These features make it an ideal model for determining the efficacy of CD3 targeted T cell redirecting therapies through direct assessment of T cell activation, antigen recognition and related intracellular signal transduction pathways.
"Data generated from our new CD3E models demonstrate their unique ability to guide development of bispecific T cell engagers and other T cell redirecting therapies," said Dr Davy Ouyang, Director of Translational Oncology at CrownBio. "We are very excited about the potential these innovative models have to uncover new insights in the discovery and development of cutting-edge I/O agents."
Crown Bioscience is a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research.
Learn more about CrownBio's new CD3E model by visiting https://www.crownbio.com/immuno-oncology/hugemm/cd3e-mouse-model
-- BERNAMA
Friday 27 April 2018
Mobile Factory develops its blockchain related services project
KUALA LUMPUR, April 25 (Bernama) -- Mobile Factory Inc today announced the outline and future prospects of its 'blockchain related services' developed on Jan 19, 2018.
In the first phase Mobile Factory, headquartered in Shinagawa-ku, Tokyo, Japan plans to offer a mobile compatible browser with cryptocurrency wallet, 'pochi' plan for release summer 2018 providing users to manage their cryptocurrency in a user friendly environment.
This is part of a three phase release and Research and Development (R&D) is in progress, a statement said.
'Pochi' can increase the contact between company and cryptocurrency users and it would be possible for the company to aim for a key position in the cryptocurrency economy, where further expansion is expected in the future.
Phase two of the project is the release of an application platform, 'uniqys' which currently under R&D designed to make users easily use applications with 'pochi'. The platform will be possible for application developers to provide services in an environment with higher user satisfaction.
The company will create a game on ‘uniqys´ at the phase three of the project and preparations is made to release it at the same time as the release of application platform 'uniqys'.
The game will reflect the game development experience and knowledge that the company has cultivated until now and they are planning a game that will give users a new play experience with various applications added in future.
The company aims to build a distributed ecosystem to create a new economy that maximises the use of blockchain technology that is expected to be used in various places in society including the entertainment field, the statement said.
-- BERNAMA
In the first phase Mobile Factory, headquartered in Shinagawa-ku, Tokyo, Japan plans to offer a mobile compatible browser with cryptocurrency wallet, 'pochi' plan for release summer 2018 providing users to manage their cryptocurrency in a user friendly environment.
This is part of a three phase release and Research and Development (R&D) is in progress, a statement said.
'Pochi' can increase the contact between company and cryptocurrency users and it would be possible for the company to aim for a key position in the cryptocurrency economy, where further expansion is expected in the future.
Phase two of the project is the release of an application platform, 'uniqys' which currently under R&D designed to make users easily use applications with 'pochi'. The platform will be possible for application developers to provide services in an environment with higher user satisfaction.
The company will create a game on ‘uniqys´ at the phase three of the project and preparations is made to release it at the same time as the release of application platform 'uniqys'.
The game will reflect the game development experience and knowledge that the company has cultivated until now and they are planning a game that will give users a new play experience with various applications added in future.
The company aims to build a distributed ecosystem to create a new economy that maximises the use of blockchain technology that is expected to be used in various places in society including the entertainment field, the statement said.
-- BERNAMA
15 researchers for 13th Hakuho Foundation Japanese Research Fellowship
TOKYO, April 27 (Bernama) -- Fifteen researchers have been invited by The Hakuho Foundation - a public interest incorporated foundation in Tokyo, Japan - to participate in the 13th Hakuho Foundation Japanese Research Fellowship.
Selected were those from Bangladesh, Bulgaria, China, South Korea, Taiwan, Turkey, Ukraine and USA, a statement said.
Four researchers were selected in the Japanese language and Japanese-language education research category and eleven in the Japanese literature and Japanese culture research category. The fellowship period is from Sept 1, 2018-Aug 31, 2019 - (either long-term (1 year) or short-term (6 months)).
The receiving organisations are -- International Research Centre for Japanese Studies, The Japan Foundation Japanese-Language Institute, Urawa, Kyoto University, National Institute for Japanese Language and Linguistics, Ochanomizu University, Ritsumeikan University, Tokyo University of Foreign Studies and Waseda University.
The Hakuho Foundation, a public interest incorporated foundation based in Tokyo, Japan, was established in 1970 to commemorate the 75th anniversary of the founding of Hakuhodo Inc., a major Japanese advertising company.
The foundation program invites leading international researchers to Japan to further strengthen the fundamentals of international research into Japan and deepening understanding of Japan.
The Foundation's website for details - About the Hakuho Foundation Japanese Research Fellowship: https://www.hakuhofoundation.or.jp/en/program/
-- BERNAMA
Selected were those from Bangladesh, Bulgaria, China, South Korea, Taiwan, Turkey, Ukraine and USA, a statement said.
Four researchers were selected in the Japanese language and Japanese-language education research category and eleven in the Japanese literature and Japanese culture research category. The fellowship period is from Sept 1, 2018-Aug 31, 2019 - (either long-term (1 year) or short-term (6 months)).
The receiving organisations are -- International Research Centre for Japanese Studies, The Japan Foundation Japanese-Language Institute, Urawa, Kyoto University, National Institute for Japanese Language and Linguistics, Ochanomizu University, Ritsumeikan University, Tokyo University of Foreign Studies and Waseda University.
The Hakuho Foundation, a public interest incorporated foundation based in Tokyo, Japan, was established in 1970 to commemorate the 75th anniversary of the founding of Hakuhodo Inc., a major Japanese advertising company.
The foundation program invites leading international researchers to Japan to further strengthen the fundamentals of international research into Japan and deepening understanding of Japan.
The Foundation's website for details - About the Hakuho Foundation Japanese Research Fellowship: https://www.hakuhofoundation.or.jp/en/program/
-- BERNAMA
Snoopy "Peanuts" Museum Tokyo reaches its grand finale
TOKYO, April 27 (Bernama) -- Having welcomed its one millionth visitor on March 29, 2018, Snoopy Museum Tokyo completes its term in September 2018 and reaches its grand finale with the final exhibition titled "FRIENDSHIP IN PEANUTS" from April 21, 2018 to Sept 24, 2018.
The museum depicts characters like Snoopy and his owner Charlie Brown, depicted by Charles M. Schulz over 50 years through "Peanuts". It also exhibits the oldest original drawings of "Peanuts", a statement said.
The final exhibition at the museum, which opened in April 2016, will offer the humorous yet pathetic dialogues through approximately 80 pieces of precious original drawing that shows the author's fresh strokes, and new animation works, a statement said.
The location of the museum is 5-6-20 Roppongi, Minato-ku, Tokyo - a 7-minute walk from Tokyo Metro Roppongi Station, 10-minute walk from Azabu-Juban Station.
For details please go to Snoopy Museum Tokyo official website: www.snoopymuseum.tokyo/en;Official Facebook page: https://www.facebook.com/snoopymuseumtokyo/; Official Twitter account: https://twitter.com/snoopy_m_tokyo
-- BERNAMA
The museum depicts characters like Snoopy and his owner Charlie Brown, depicted by Charles M. Schulz over 50 years through "Peanuts". It also exhibits the oldest original drawings of "Peanuts", a statement said.
The final exhibition at the museum, which opened in April 2016, will offer the humorous yet pathetic dialogues through approximately 80 pieces of precious original drawing that shows the author's fresh strokes, and new animation works, a statement said.
The location of the museum is 5-6-20 Roppongi, Minato-ku, Tokyo - a 7-minute walk from Tokyo Metro Roppongi Station, 10-minute walk from Azabu-Juban Station.
For details please go to Snoopy Museum Tokyo official website: www.snoopymuseum.tokyo/en;Official Facebook page: https://www.facebook.com/snoopymuseumtokyo/; Official Twitter account: https://twitter.com/snoopy_m_tokyo
-- BERNAMA
Record network growth for Cloudflare
SAN FRANCISCO, April 27 (Bernama) -- Cloudflare - a leading Internet performance and security company - today announced record network growth by nearly 30 percent in the first quarter of 2018 and launched three new products and a major collaboration.
The company also added 32 new cities, growing its network to 151 points of presence globally. Cloudflare now protects more than 8 million domains, websites, APIs, mobile applications, and anything connected to the Internet, a statement said.
"At Cloudflare´s core is its network, which we've built to be flexible, efficient, and able to perform any task in any given location," said Matthew Prince, co-founder and CEO of Cloudflare. "In this last quarter, we grew our network at record pace, bringing our network closer to everyone on earth. This means that we´re able to roll out products at a global scale for users everywhere."
The three major new products in the quarter are Cloudflare Access, a solution that makes accessing internal enterprise applications fast and easy, Cloudflare Workers, a better, faster way for developers to deploy and execute their code directly at the edge of Cloudflare's global network and Cloudflare Mobile SDK, a free solution that enables any mobile app developer to understand network performance and metrics.
Also announced today is the Cloudflare and IBM collaboration to extend security and performance from the cloud to the network edge. Through the collaboration, IBM launched Cloud Internet Services, a one-stop shop for Cloudflare's security and performance capabilities designed to protect enterprise public-facing web content and applications.
Now Cloudflare's solutions can be deployed in IBM's customers' environments, including public, private, hybrid cloud, or on-premise. Additionally, IBM is now an authorized reseller of Cloudflare´s suite of security and performance edge services.
Cloudflare now has more than 625 employees, up from 400 just over a year ago. The company continues to grow its engineering, sales, marketing, and support teams across its offices in San Francisco, Austin, Champaign, IL, London, New York, Washington D.C., and Singapore.
To learn more about Cloudflare please check: www.cloudflare.com/@cloudflare; cloudflare Network Map; Cloudflare Blog
-- BERNAMA
The company also added 32 new cities, growing its network to 151 points of presence globally. Cloudflare now protects more than 8 million domains, websites, APIs, mobile applications, and anything connected to the Internet, a statement said.
"At Cloudflare´s core is its network, which we've built to be flexible, efficient, and able to perform any task in any given location," said Matthew Prince, co-founder and CEO of Cloudflare. "In this last quarter, we grew our network at record pace, bringing our network closer to everyone on earth. This means that we´re able to roll out products at a global scale for users everywhere."
The three major new products in the quarter are Cloudflare Access, a solution that makes accessing internal enterprise applications fast and easy, Cloudflare Workers, a better, faster way for developers to deploy and execute their code directly at the edge of Cloudflare's global network and Cloudflare Mobile SDK, a free solution that enables any mobile app developer to understand network performance and metrics.
Also announced today is the Cloudflare and IBM collaboration to extend security and performance from the cloud to the network edge. Through the collaboration, IBM launched Cloud Internet Services, a one-stop shop for Cloudflare's security and performance capabilities designed to protect enterprise public-facing web content and applications.
Now Cloudflare's solutions can be deployed in IBM's customers' environments, including public, private, hybrid cloud, or on-premise. Additionally, IBM is now an authorized reseller of Cloudflare´s suite of security and performance edge services.
Cloudflare now has more than 625 employees, up from 400 just over a year ago. The company continues to grow its engineering, sales, marketing, and support teams across its offices in San Francisco, Austin, Champaign, IL, London, New York, Washington D.C., and Singapore.
To learn more about Cloudflare please check: www.cloudflare.com/@cloudflare; cloudflare Network Map; Cloudflare Blog
-- BERNAMA
Thursday 26 April 2018
Malware and brute force attacks dominate Asia Pacific
KUALA LUMPUR, April 26 (Bernama) -- Viruses and worms accounted for 66 per cent of malware, nearly three times the global percentage of 23 per cent.
The 2018 Global Threat Intelligence Report (GTIR), published by NTT Security, shows an increasing trend of ransomware in nearly every region, playing a role in only 2 per cent of malware-related attacks for APAC (Asia Pacific) targets.
Conversely, brute force attacks accounted for 26 per cent of all attacks in the region, but were ranked the twelfth most common attack type in both the Americas and Europe, the Middle East and Africa (EMEA), a statement said.
Brute force attacks spiked to 64 per cent for the retail and education sectors in APAC and was the leading attack type in the region, at 26 per cent.
A brute force attack usually uses automated software to perform many consecutive guesses to identify usernames and passwords. Simple passwords can be broken in seconds or minutes depending on password complexity.
Senior Manager of the Threat Intelligence Communication Team, Global Threat Intelligence Centre at NTT Security, Jon Heimerl said: " The GTIR clearly demonstrates the uphill battle organisations face in achieving an optimal balance between operational security and compliance initiatives.
"In order to be successful they cannot afford to be complacent and must recognise that having a firm grasp on what it takes to remain secure is a fundamental part of everyday business operations.
"In an ever-evolving threat landscape, defending your organization is no small task, but focusing on key areas outlined in our report, such as incident response plans, multi-factor and strong authentication, comprehensive and reliable patching and usable but effective security measures, can help to build the security posture of an organisation," Heimerl added.
The 2018 GTIR report gathers data from NTT Security monitoring, management, and incident response operations. It also includes details from NTT Security research sources including global honeypots and sandboxes in over 100 countries in environments independent from institutional infrastructures.
--BERNAMA
The 2018 Global Threat Intelligence Report (GTIR), published by NTT Security, shows an increasing trend of ransomware in nearly every region, playing a role in only 2 per cent of malware-related attacks for APAC (Asia Pacific) targets.
Conversely, brute force attacks accounted for 26 per cent of all attacks in the region, but were ranked the twelfth most common attack type in both the Americas and Europe, the Middle East and Africa (EMEA), a statement said.
Brute force attacks spiked to 64 per cent for the retail and education sectors in APAC and was the leading attack type in the region, at 26 per cent.
A brute force attack usually uses automated software to perform many consecutive guesses to identify usernames and passwords. Simple passwords can be broken in seconds or minutes depending on password complexity.
Senior Manager of the Threat Intelligence Communication Team, Global Threat Intelligence Centre at NTT Security, Jon Heimerl said: " The GTIR clearly demonstrates the uphill battle organisations face in achieving an optimal balance between operational security and compliance initiatives.
"In order to be successful they cannot afford to be complacent and must recognise that having a firm grasp on what it takes to remain secure is a fundamental part of everyday business operations.
"In an ever-evolving threat landscape, defending your organization is no small task, but focusing on key areas outlined in our report, such as incident response plans, multi-factor and strong authentication, comprehensive and reliable patching and usable but effective security measures, can help to build the security posture of an organisation," Heimerl added.
The 2018 GTIR report gathers data from NTT Security monitoring, management, and incident response operations. It also includes details from NTT Security research sources including global honeypots and sandboxes in over 100 countries in environments independent from institutional infrastructures.
--BERNAMA
Wednesday 25 April 2018
MedicCoin gives crypto rewards in global health awareness programme
KUALA LUMPUR, April 25 (Bernama) MedicCoin is introducing multiple ways to earn crypto as a reward for health conscious uses of blockchain technology globally.
Among the innovations are MedicWalk app, where users can acquire MedicCoin by installing the app and stay active which is part of the company´s visions to promote living an active lifestyle. The app will be launched within the next few weeks, a statement said.
MedicCoin is also offering the opportunity to earn coins by donating computer power to Stanford University´s Folding@home program, which helps scientists solve computer calculations related to finding cures for Alzheimer´s, Parkinson´s, Huntington´s, cancers and other types of diseases.
The innovation includes following doctor instructions whereby physicians who join and support the network will be provided with MedicCoin for rewarding patients who show up for appointments and follow instructions.
Another incentive is the MedicEMR , the first free opensource EMR software accepting payments by crypto. The software aims to increase access to high-quality medical care for all people by rewarding physicians and patients with MedicCoin for using the software.
Also made available is MedicPhone, an integrated TeleMedicine App for people who face immobility challenges or logistical complications. MedicPhone will integrate MedicEMR and accept MedicCoin and other payment methods to give access to board-certified doctors 24 hours a day and seven days a week.
MedicCoin is also innovating integrated privacy technology to ensure users can maintain a confidential transaction history with different healthcare providers, individuals, merchants and other establishments. This is InstantX which enables users to avoid the long delays as MedicCoin is viable wherever conventional payment methods are used.
The MedicCoin community can engage multiple communication channels and platforms on future announcements to ensure ongoing media coverage via syndicated articles and editorials, journalist outreach, a MedicCoin-branded news portal, and various engagement initiatives.
MedicCoin is a blockchain-based crypto focused on promoting health and philanthropy throughout the world by rewarding individuals in various ways for being healthy. More information at https://mediccoin.com/
--BERNAMA
Among the innovations are MedicWalk app, where users can acquire MedicCoin by installing the app and stay active which is part of the company´s visions to promote living an active lifestyle. The app will be launched within the next few weeks, a statement said.
MedicCoin is also offering the opportunity to earn coins by donating computer power to Stanford University´s Folding@home program, which helps scientists solve computer calculations related to finding cures for Alzheimer´s, Parkinson´s, Huntington´s, cancers and other types of diseases.
The innovation includes following doctor instructions whereby physicians who join and support the network will be provided with MedicCoin for rewarding patients who show up for appointments and follow instructions.
Another incentive is the MedicEMR , the first free opensource EMR software accepting payments by crypto. The software aims to increase access to high-quality medical care for all people by rewarding physicians and patients with MedicCoin for using the software.
Also made available is MedicPhone, an integrated TeleMedicine App for people who face immobility challenges or logistical complications. MedicPhone will integrate MedicEMR and accept MedicCoin and other payment methods to give access to board-certified doctors 24 hours a day and seven days a week.
MedicCoin is also innovating integrated privacy technology to ensure users can maintain a confidential transaction history with different healthcare providers, individuals, merchants and other establishments. This is InstantX which enables users to avoid the long delays as MedicCoin is viable wherever conventional payment methods are used.
The MedicCoin community can engage multiple communication channels and platforms on future announcements to ensure ongoing media coverage via syndicated articles and editorials, journalist outreach, a MedicCoin-branded news portal, and various engagement initiatives.
MedicCoin is a blockchain-based crypto focused on promoting health and philanthropy throughout the world by rewarding individuals in various ways for being healthy. More information at https://mediccoin.com/
--BERNAMA
Tuesday 24 April 2018
Extech Electronic marks 40th anniversary with future strategic plans
KUALA LUMPUR, April 24 (Bernama) -- Extech Electronic Co (EEC), the industry-leading innovator of electrical testing equipment celebrated its 40th anniversary launching a website - www.eecextech.com - to inspire customer engagement through a modern, user-friendly online platform integrating social media and direct engagement.
EEC is also sharing its rich history, forging a new course for the future with marking the quality of electrical equipment while protecting the safety of manufacturing workers and consumers worldwide, a statement said.
Other plans include:
-- the company is striving to advance the EEC user experience through multi-language support for its feature-rich solutions, the statement said.
-- EEC will revolutionise its approach by shifting to a solution-oriented focus, bringing a various of game-changing solutions to multiple industries. This transformation draws upon four decades of experience creating testing solutions for components that drive and array of outstanding multinational brands such as Apple, Dyson, Panasonic and others.
-- through its EEC Service Program, manufacturers will gain unprecedented access to the company's expertise in general electrical safety, testing instrumentation and equipment, and testing standards, while EEC provide advanced training on state-of-the-art industry applications and technology.
-- established a global presence across 40 countries, extending its reach further with EEC Everywhere -- a strategic shift that marks an aggressive expansion from direct to indirect sales, opening the door to more distributers and greater service coverage than ever before.
Customers can now expect almost unlimited availability and unprecedented response times for their requests, enhancing overall customer satisfaction.
-- BERNAMA
EEC is also sharing its rich history, forging a new course for the future with marking the quality of electrical equipment while protecting the safety of manufacturing workers and consumers worldwide, a statement said.
Other plans include:
-- the company is striving to advance the EEC user experience through multi-language support for its feature-rich solutions, the statement said.
-- EEC will revolutionise its approach by shifting to a solution-oriented focus, bringing a various of game-changing solutions to multiple industries. This transformation draws upon four decades of experience creating testing solutions for components that drive and array of outstanding multinational brands such as Apple, Dyson, Panasonic and others.
-- through its EEC Service Program, manufacturers will gain unprecedented access to the company's expertise in general electrical safety, testing instrumentation and equipment, and testing standards, while EEC provide advanced training on state-of-the-art industry applications and technology.
-- established a global presence across 40 countries, extending its reach further with EEC Everywhere -- a strategic shift that marks an aggressive expansion from direct to indirect sales, opening the door to more distributers and greater service coverage than ever before.
Customers can now expect almost unlimited availability and unprecedented response times for their requests, enhancing overall customer satisfaction.
-- BERNAMA
China CEIS and HSF release 'Xinhua HSF Price Indices'
KUALA LUMPUR, April 24 (Bernama) -- China Economic Information Service (CEIS) and Haiken Group (HSF) recently released 'Xinhua HSF Price Indices' in Haikou, capital city of south China's Hainan Province.
"Xinhua HSF Price Indices intuitively present the price changes of natural rubber, pepper and areca nut, and objectively and accurately reflect factor price fluctuations in different links of the industry chain, thereby providing an open and transparent price guide to the industries," said vice-president of CEIS, Liu Mingxia.
"The indices help players engaged in the production, circulation and processing to duly and accurately study and predict market prices whereby they rationally guide market expectations," added Liu.
The indices include China Natural Rubber Price Index, Pepper Price Index and Areca Nut Price Index, a statement said.
Xinhua HSF China Natural Rubber Price Index is China's first price index system supported by the spot market trade data and connecting the rubber production and sales comprising four sub-indices including concentrated latex, latex, mixed rubber and standard rubber. The index is an important carrier showcasing the influence of China's rubber industry.
As a leader in natural rubber producer and major tropical crop producer in China, HSF has a natural rubber area of 3.69 million mu (15 mu equal one hectare) and a tropical crop area of 1.5 million mu.
Chairman of HSF, Yang Sitao said HSF will widen the cooperation with CEIS to gradually improve the system of Xinhua HSF Price Indices and enrich index dimensions to create internationally influential and credible price indices, and build HSF into a new growth pole for Hainan's economy as well as a characteristic national tropical agriculture demonstration zone.
CEIS is a wholly-owned company of Xinhua News Agency and boasts five national-level platforms including Xinhua Finance, Xinhua Silkroad, Xinhua Credit, Shanghai Petroleum and Natural Gas Exchange (SHPGX) and Xinhua Think Tank.
--BERNAMA
"Xinhua HSF Price Indices intuitively present the price changes of natural rubber, pepper and areca nut, and objectively and accurately reflect factor price fluctuations in different links of the industry chain, thereby providing an open and transparent price guide to the industries," said vice-president of CEIS, Liu Mingxia.
"The indices help players engaged in the production, circulation and processing to duly and accurately study and predict market prices whereby they rationally guide market expectations," added Liu.
The indices include China Natural Rubber Price Index, Pepper Price Index and Areca Nut Price Index, a statement said.
Xinhua HSF China Natural Rubber Price Index is China's first price index system supported by the spot market trade data and connecting the rubber production and sales comprising four sub-indices including concentrated latex, latex, mixed rubber and standard rubber. The index is an important carrier showcasing the influence of China's rubber industry.
As a leader in natural rubber producer and major tropical crop producer in China, HSF has a natural rubber area of 3.69 million mu (15 mu equal one hectare) and a tropical crop area of 1.5 million mu.
Chairman of HSF, Yang Sitao said HSF will widen the cooperation with CEIS to gradually improve the system of Xinhua HSF Price Indices and enrich index dimensions to create internationally influential and credible price indices, and build HSF into a new growth pole for Hainan's economy as well as a characteristic national tropical agriculture demonstration zone.
CEIS is a wholly-owned company of Xinhua News Agency and boasts five national-level platforms including Xinhua Finance, Xinhua Silkroad, Xinhua Credit, Shanghai Petroleum and Natural Gas Exchange (SHPGX) and Xinhua Think Tank.
--BERNAMA
Monday 23 April 2018
Bakery China 2018 invites over 140,000 visitors for exhibition in May
KUALA LUMPUR, April 23 (Bernama) -- China Association of Bakery and Confectionery Industry (CABCI) and Bakery China Exhibitions Co Ltd will organise Bakery China 2018 on May 9 to 12 at the Shanghai New International Expo Center.
The exhibition brings more than 140,000 professional visitors from over 110 countries and regions who will experience the innovation of China's bakery industry, a statement said.
With an exhibition area of over 200,000 square meters this year, Bakery China 2018 hopes to attract more than 2,100 exhibitors worldwide.
China's bakery industry has boasted a 20 per cent average growth rate between 2003 and 2016 and in the forthcoming months, the country is expected to become the largest producer and consumer of bakery products.
Fast urbanisation and diversification of people's diets will be the key drivers for the growth of the bakery industry in China, the statement added.
According to statistics on bakery enterprises on a state-designated scale from the National Bureau of Statistics of China, in 2017, China's bakery and confectionery production (including pastry/breads, biscuits, chocolates, frozen beverages, instant noodles and sweetmeats) totalled 35.899 million tons, with a prime operating revenue of RMB 743.178 billion (US$118.04 billion / RM460.30 billion), at a year-on-year growth of 8.29 per cent.
According to CABCI, based on a population of 1.37 billion, China's per capita annual consumption of bread in 2017 was only 4.4kg. Compared to an average of 10kg in South Korea, over 20kg in Japan and over 70 to 80kg in the US and Western European countries -- China holds great potential for growth and expansion.
As an important indicator of China's robust growth on bakery, Bakery China (www.bakerychina.com) was launched 21 years ago and has developed into the world's largest exhibition in this area.
--BERNAMA
The exhibition brings more than 140,000 professional visitors from over 110 countries and regions who will experience the innovation of China's bakery industry, a statement said.
With an exhibition area of over 200,000 square meters this year, Bakery China 2018 hopes to attract more than 2,100 exhibitors worldwide.
China's bakery industry has boasted a 20 per cent average growth rate between 2003 and 2016 and in the forthcoming months, the country is expected to become the largest producer and consumer of bakery products.
Fast urbanisation and diversification of people's diets will be the key drivers for the growth of the bakery industry in China, the statement added.
According to statistics on bakery enterprises on a state-designated scale from the National Bureau of Statistics of China, in 2017, China's bakery and confectionery production (including pastry/breads, biscuits, chocolates, frozen beverages, instant noodles and sweetmeats) totalled 35.899 million tons, with a prime operating revenue of RMB 743.178 billion (US$118.04 billion / RM460.30 billion), at a year-on-year growth of 8.29 per cent.
According to CABCI, based on a population of 1.37 billion, China's per capita annual consumption of bread in 2017 was only 4.4kg. Compared to an average of 10kg in South Korea, over 20kg in Japan and over 70 to 80kg in the US and Western European countries -- China holds great potential for growth and expansion.
As an important indicator of China's robust growth on bakery, Bakery China (www.bakerychina.com) was launched 21 years ago and has developed into the world's largest exhibition in this area.
--BERNAMA
Friday 20 April 2018
Thursday 19 April 2018
P&G ACQUIRES THE CONSUMER HEALTH BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY
Strengthens Portfolio, Category Footprint in Top 15 Global OTC Markets
Replaces and Improves Upon Successful PGT Healthcare Joint Venture
CINCINNATI, April 19 (Bernama-BUSINESS WIRE) -- The Procter & Gamble Company (NYSE:PG) today announced it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for a purchase price of approximately 3.4 billion euro.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180418006692/en/
This acquisition enables P&G to expand its successful consumer health care business by adding a fast-growing portfolio of differentiated, physician-supported brands across a broad geographic footprint. It also provides P&G with strong health care commercial and supply capabilities, deep technical mastery and proven consumer health care leadership that will complement P&G's existing consumer Health Care capabilities and brands such as Vicks, Metamucil, Pepto-Bismol, Crest and Oral-B.
“We like the steady, broad-based growth of the OTC Health Care market and are pleased to add the Consumer Health portfolio and people of Merck KGaA, Darmstadt, Germany, to the P&G family,” said David Taylor, Chairman of the Board, President and Chief Executive Officer.
P&G’s acquisition of the Consumer Health business of Merck KGaA, Darmstadt, Germany, will improve P&G’s OTC geographic scale, brand portfolio and category footprint in the vast majority of the world’s top 15 OTC markets. These brands provide great solutions in relieving muscle, joint and back pain, colds and headaches, as well as supporting physical activity and mobility, many of which are treatment areas not currently addressed in P&G’s portfolio.
“Over the past few years, our Health Care business has delivered consistent growth and strong shareholder value creation,“ said Steve Bishop, Group President, Global Health Care. “The Consumer Health business of Merck KGaA, Darmstadt, Germany, brings a strong set of brands, products and capabilities, and provides an attractive and complementary footprint to further fuel growth as we continue to grow our existing leading brands.”
The acquisition of the Consumer Health business of Merck KGaA, Darmstadt, Germany, replaces and improves upon the highly successful PGT Healthcare joint venture P&G had with Teva Pharmaceutical Industries (NYSE: TEVA), which will be terminated July 1, 2018, pending regulatory approvals.
The PGT Healthcare joint venture delivered disproportionate top- and bottom-line growth and established a major presence in over 50 countries since its formation. However, following a recent review, Teva and P&G concluded that priorities and strategies were no longer aligned and agreed to terms where it would be mutually beneficial to terminate the partnership. PGT product assets will return to their respective parent companies to reestablish independent OTC businesses.
The $1 billion Consumer Health business of Merck KGaA, Darmstadt, Germany, grew 6% over the past two years and provides a broad range of OTC product remedies to relieve muscle, joint and back pain, colds and headaches as well as products for supporting physical activity and mobility. Top brands include Neurobion, Dolo-Neurobion, Femibion, Nasivin, Bion3, Seven Seas and Kytta, along with many others. These are sold primarily in Europe, Latin America and Asia.
“These leading brands and the great employees of the Consumer Health business of Merck KGaA, Darmstadt, Germany, will complement our Personal Health Care business very well,” said Tom Finn, President, P&G Global Personal Health Care. “This acquisition helps us continue to drive sales and profit growth for P&G by providing the capabilities and portfolio scale we need to operate a winning global OTC business on our own, without the aid of a health care partner.”
“The divestment of our Consumer Health is an important step in our strategic focus on innovation-driven businesses within Healthcare, Life Science and Performance Materials. It is a clear demonstration of our continued commitment to actively shape our portfolio as a leading science and technology company,” said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. “Consumer Health is a strong business that deserves the best possible opportunities for its future development. With P&G we have found a strong, highly recognized player who has the necessary scale to successfully drive the business going forward.”
“P&G’s global scale and strategic interest in the health and well-being of consumers provide an excellent basis for accelerating growth, leveraging our teams’ capabilities and expanding the Consumer Health business profitably. The marketed portfolios, product pipelines and geographic footprints of both businesses are highly complementary,” said Belén Garijo, Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO Healthcare. “With this transaction, we continue to rigorously deliver on our strategy to become a global specialty innovator and bring breakthrough medicines to patients.”
The Consumer Health business of Merck KGaA, Darmstadt, Germany, is active across 44 countries and includes more than 900 products. P&G is targeting to close this deal during the 2018/19 fiscal year, subject to customary closing conditions and regulatory clearances.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.
Forward Looking Statements:
Certain statements in this release or presentation, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to affect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters and acts of war or terrorism; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials, and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third party information technology systems, networks and services, and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions (including the United Kingdom’s decision to leave the European Union) and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, intellectual property, antitrust, data protection, tax, environmental, and accounting and financial reporting) and to resolve pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations including maintaining our intended tax treatment of divestiture transactions; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; and (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180418006692/en/
Contact
P&G Media:
Heather Huff, +1-513-622-1810
Huff.ha@pg.com
or
Tressie Rose, +1-513-983-4929
Rose.t.8@pg.com
or
P&G Investor Relations:
John Chevalier, +1-513-983-9974
Chevalier.jt@pg.com
Source : Procter & Gamble
Replaces and Improves Upon Successful PGT Healthcare Joint Venture
CINCINNATI, April 19 (Bernama-BUSINESS WIRE) -- The Procter & Gamble Company (NYSE:PG) today announced it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for a purchase price of approximately 3.4 billion euro.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180418006692/en/
This acquisition enables P&G to expand its successful consumer health care business by adding a fast-growing portfolio of differentiated, physician-supported brands across a broad geographic footprint. It also provides P&G with strong health care commercial and supply capabilities, deep technical mastery and proven consumer health care leadership that will complement P&G's existing consumer Health Care capabilities and brands such as Vicks, Metamucil, Pepto-Bismol, Crest and Oral-B.
“We like the steady, broad-based growth of the OTC Health Care market and are pleased to add the Consumer Health portfolio and people of Merck KGaA, Darmstadt, Germany, to the P&G family,” said David Taylor, Chairman of the Board, President and Chief Executive Officer.
P&G’s acquisition of the Consumer Health business of Merck KGaA, Darmstadt, Germany, will improve P&G’s OTC geographic scale, brand portfolio and category footprint in the vast majority of the world’s top 15 OTC markets. These brands provide great solutions in relieving muscle, joint and back pain, colds and headaches, as well as supporting physical activity and mobility, many of which are treatment areas not currently addressed in P&G’s portfolio.
“Over the past few years, our Health Care business has delivered consistent growth and strong shareholder value creation,“ said Steve Bishop, Group President, Global Health Care. “The Consumer Health business of Merck KGaA, Darmstadt, Germany, brings a strong set of brands, products and capabilities, and provides an attractive and complementary footprint to further fuel growth as we continue to grow our existing leading brands.”
The acquisition of the Consumer Health business of Merck KGaA, Darmstadt, Germany, replaces and improves upon the highly successful PGT Healthcare joint venture P&G had with Teva Pharmaceutical Industries (NYSE: TEVA), which will be terminated July 1, 2018, pending regulatory approvals.
The PGT Healthcare joint venture delivered disproportionate top- and bottom-line growth and established a major presence in over 50 countries since its formation. However, following a recent review, Teva and P&G concluded that priorities and strategies were no longer aligned and agreed to terms where it would be mutually beneficial to terminate the partnership. PGT product assets will return to their respective parent companies to reestablish independent OTC businesses.
The $1 billion Consumer Health business of Merck KGaA, Darmstadt, Germany, grew 6% over the past two years and provides a broad range of OTC product remedies to relieve muscle, joint and back pain, colds and headaches as well as products for supporting physical activity and mobility. Top brands include Neurobion, Dolo-Neurobion, Femibion, Nasivin, Bion3, Seven Seas and Kytta, along with many others. These are sold primarily in Europe, Latin America and Asia.
“These leading brands and the great employees of the Consumer Health business of Merck KGaA, Darmstadt, Germany, will complement our Personal Health Care business very well,” said Tom Finn, President, P&G Global Personal Health Care. “This acquisition helps us continue to drive sales and profit growth for P&G by providing the capabilities and portfolio scale we need to operate a winning global OTC business on our own, without the aid of a health care partner.”
“The divestment of our Consumer Health is an important step in our strategic focus on innovation-driven businesses within Healthcare, Life Science and Performance Materials. It is a clear demonstration of our continued commitment to actively shape our portfolio as a leading science and technology company,” said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. “Consumer Health is a strong business that deserves the best possible opportunities for its future development. With P&G we have found a strong, highly recognized player who has the necessary scale to successfully drive the business going forward.”
“P&G’s global scale and strategic interest in the health and well-being of consumers provide an excellent basis for accelerating growth, leveraging our teams’ capabilities and expanding the Consumer Health business profitably. The marketed portfolios, product pipelines and geographic footprints of both businesses are highly complementary,” said Belén Garijo, Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO Healthcare. “With this transaction, we continue to rigorously deliver on our strategy to become a global specialty innovator and bring breakthrough medicines to patients.”
The Consumer Health business of Merck KGaA, Darmstadt, Germany, is active across 44 countries and includes more than 900 products. P&G is targeting to close this deal during the 2018/19 fiscal year, subject to customary closing conditions and regulatory clearances.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.
Forward Looking Statements:
Certain statements in this release or presentation, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to affect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters and acts of war or terrorism; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials, and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third party information technology systems, networks and services, and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions (including the United Kingdom’s decision to leave the European Union) and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, intellectual property, antitrust, data protection, tax, environmental, and accounting and financial reporting) and to resolve pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations including maintaining our intended tax treatment of divestiture transactions; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; and (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180418006692/en/
Contact
P&G Media:
Heather Huff, +1-513-622-1810
Huff.ha@pg.com
or
Tressie Rose, +1-513-983-4929
Rose.t.8@pg.com
or
P&G Investor Relations:
John Chevalier, +1-513-983-9974
Chevalier.jt@pg.com
Source : Procter & Gamble
EMQ and Vietnam HDBank boost remittance capabilities across Southeast Asia
KUALA LUMPUR, April 19 (Bernama) -- EMQ -- a financial technology
innovator with extensive financial settlement network in Asia and HDBank, one
of Vietnam's leading commercial bank have partnered to support the growing
demand for instant remittances in Vietnam and across Southeast Asia.
Co-founder and chief executive officer of EMQ, Max Liu said the partnership marks a milestone for the company as it continues strategic expansion across the region and delivers innovative value-added financial services.
"Remittances from overseas workers constitute a vital part of the economy of many developing nations such as Vietnam -- a leading recipient of global remittances and contributes to seven per cent of the country's gross domestic product (GDP), according to the World Bank."
"Our partnership with HDBank will boost our capabilities in Vietnam, making financial services more accessible and inclusive for the overseas workers and their families across the country," he added.
As one of the top 10 joint stock commercial banks and operating for more than 28 years in Vietnam, HDBank has built strong financial capabilities to offer a wide variety of financial services across its 240 branches in the country.
The partnership leverages EMQ's financial settlement network across Asia, which will enhance HDBank's ability to deliver accessible and convenient remittance services in Vietnam.
EMQ currently has footprint in Hong Kong, India, Indonesia, Vietnam and Philippines, which plans to expand across other key business markets in Asia, North America, Europe and the Middle East.
-- BERNAMA
Subscribe to:
Posts (Atom)